In the BioHarmony Drug Report Database
Edarbi (azilsartan kamedoxomil) is a small molecule pharmaceutical. Azilsartan kamedoxomil was first approved as Edarbi on 2011-02-25. It is used to treat hypertension in the USA. It has been approved in Europe to treat hypertension. Edarbi’s patents are valid until 2028-03-26 (FDA).
Image (chem structure or protein)